Infectious Diseases (except HIV/AIDS)
-
Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein
This article has 8 authors:Reviewed by ScreenIT
-
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities
This article has 7 authors:Reviewed by ScreenIT
-
Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1–2 IgG antibody titers in healthcare personnel
This article has 12 authors:Reviewed by ScreenIT
-
Survey of Direct and Indirect Effects of COVID-19 on Eyes and the Common Ocular Manifestations
This article has 6 authors:Reviewed by ScreenIT
-
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study
This article has 9 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021
This article has 38 authors:Reviewed by ScreenIT
-
Modeling brings additional insights into the kinetics of SARS-CoV-2 neutralizing antibody
This article has 4 authors:Reviewed by ScreenIT
-
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
This article has 20 authors:Reviewed by ScreenIT
-
Long distance airborne transmission of SARS-CoV-2: rapid systematic review
This article has 7 authors:Reviewed by ScreenIT
-
SARS-CoV-2 variant transmission in a community-health population (Mexico City, Mexico)
This article has 12 authors:Reviewed by ScreenIT